Publications for Karin Skoglund
Co-author map based on ISI articles 2007-

Publications mentioned in social media 5 times*

Keywords

vivo variant treatment transport tpmt polymorphisms patients myeloid leukemia imatinib gene enzyme cyp3a cml chronic cgp74588 cells abcg2 abcb1 6-mp

Journal Articles

Karin Skoglund, Samuel Boiso, Jan-Ingvar Jönsson, Svante Vikingsson, Björn Carlsson and Henrik Green
  Single-nucleotide polymorphisms of ABCG2 increase the efficacy of tyrosine kinase inhibitors in the K562 chronic myeloid leukemia cell line
 
Altmetric usage: 1

  Pharmacogenetics & Genomics, 2014, 24(1), 52-61.
   Fulltext  PDF  

Karin Skoglund, Samuel Boiso Moreno, Maria Baytar, Jan-Ingvar Jönsson and Henrik Gréen
  ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro
 
Altmetric usage: 4

  Pharmacogenomics and Personalized Medicine, 2013, 6, 63-72.
   Fulltext  PDF  

Anna Fyrberg, Karin Skoglund, M Wolk and Kourosh Lotfi
  A potential role of fetal hemoglobin in the development of multidrug resistance
  Biochemical and Biophysical Research Communications - BBRC, 2012, 427(3), 456-460.

Patricia Wennerstrand, Paolo Dametto, Janosch Hennig, Therése Klingstedt, Karin Skoglund, Malin Lindqvist Appell and Lars-Göran Mårtensson
  Structural Characteristics Determine the Cause of the Low Enzyme Activity of Two Thiopurine S-Methyltransferase Allelic Variants: A Biophysical Characterization of TPMT*2 and TPMT*5
  Biochemistry, 2012, 51(30), 5912-5920.
 Web of Science® Times Cited: 2

Sally A Coulthard, Christopher P F Redfern, Malin Lindqvist Appell, Karin Skoglund, Ingrid Jakobsen Falk, Andrew G Hall, Gordon A Taylor and Linda A Hogarth
  Increased Sensitivity to Thiopurines in Methylthioadenosine Phosphorylase-Deleted Cancers
  MOLECULAR CANCER THERAPEUTICS, 2011, 10(3), 495-504.
 Web of Science® Times Cited: 6

Patricia Wennerstrand, Lars-Göran Mårtensson, P Dametto, Janosch Hennig, Karin Skoglund and Curt Peterson
  Different mechanisms behind low enzyme activity in vivo of two different variants of Thiopurine S-methyltransferase, TPMT
  The FEBS Journal, 2010, 277(Suppl. 1), 257-258.

Henrik Green, Karin Skoglund, Franz Rommel, Rajaa A Mirghani and Kourosh Lotfi
  CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity
  EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66(4), 383-386.
   Fulltext  PDF  
 Web of Science® Times Cited: 18

Malin Lindqvist Appell, Karin Skoglund, Anna Karlgren, Curt Peterson, Peter Söderkvist, Irene Kidhall and Sven Almer
  Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23
  Pharmacogenetics and Genomics, 2007, 17(10), 891-895.
 Web of Science® Times Cited: 25

Conference Articles

Karin Skoglund, Samuel Boiso Moreno, Jan-Ingvar Jönsson and Henrik Green
  Functional Characterization of ABCG2 Polymorphisms and Their Influence on Tyrosine Kinase Inhibitor Effects in Chronic Myeloid Leukemia Cells in BLOOD, vol 118, issue 21, pp 1491-1491
  BLOOD, 2011.


Sally Coulthard, Christopher Redfern, Svante Vikingsson, Malin Lindqvist Appell, Karin Skoglund, Ingrid Jakobsen Falk, Andrew Hall, Gordon Taylor and Linda Hogarth
  Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers in PURINERGIC SIGNALLING, vol 6, issue , pp 33-33
  PURINERGIC SIGNALLING, 2010.


Malin Lindqvist Appell, Patricia Wennerstrand, Karin Skoglund, Mårtensson Lars-Göran, Erik Hertervig and Curt Peterson
  Explaining TPMT genotype/phenotype discrepancy by identification of a novel sequence variant, TPMT*27
  13th International Symposium on Purine and Pyrimidine metabolism in man, 2009.


Malin Lindqvist Appell, Karin Skoglund, Erik Hertervig, Peter Söderkvist and Curt Peterson
  Explaining TPMT genotype/phenotype discrepancy by identification of a novel sequence variant, TPMT*26
  Pharmacogenomics meeting Cold Spring Harbor Laboratory, 2008.


Karin Skoglund, Malin Lindqvist Appell, Sven Almér, Curt Peterson and Peter Söderkvist
  Low Expression of TPMT wild type alleles in a patient with absent TPMT activity
  UICC World Cancer Congress, 2008.


Karin Skoglund, Malin Lindqvist Appell, Sven Almér, Curt Peterson and Peter Söderkvist
  Low expression of TPMT wild type alleles in a patient with absent TPMT activity
  Pharmacogenomics, 2008.


Karin Skoglund, Malin Lindqvist Appell, Anna Karlgren, Peter Söderkvist, Curt Peterson, Irene Kidhall and Sven Almér
  Explaining TPMT Genotype/Phenotype Discrepancy by Identification of a Novel Sequence Variant, TPMT*23
  12th International Symposium on Purine and Pyrimidine Metabolism in Man, 2007.


Henrik Green, Karin Skoglund, Franz Rommel, Leif Bertilsson and Kourosh Lotfi
  Influence of CYP3A4 activity on imatinib response in paitents with chronic myeloid leukemia
  11th congress of the European Heamtology Association,2006, 2006.


Ph.D. Theses

Karin Skoglund
  Influence of CYP3A enzymes and ABC transporters on the activity of tyrosine kinase inhibitors in chronic myeloid leukemia
  2013.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.